Success Metrics

Clinical Success Rate
88.9%

Based on 16 completed trials

Completion Rate
89%(16/18)
Active Trials
0(0%)
Results Posted
25%(4 trials)
Terminated
2(10%)

Phase Distribution

Ph phase_3
2
10%
Ph phase_2
8
40%
Ph phase_1
9
45%

Phase Distribution

9

Early Stage

8

Mid Stage

2

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
9(47.4%)
Phase 2Efficacy & side effects
8(42.1%)
Phase 3Large-scale testing
2(10.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

16 of 20 finished

Non-Completion Rate

20.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

20

all time

Status Distribution
Completed(16)
Terminated(4)

Detailed Status

Completed16
Withdrawn2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
20
Active
0
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Phase 19 (47.4%)
Phase 28 (42.1%)
Phase 32 (10.5%)

Trials by Status

completed1680%
withdrawn210%
terminated210%

Recent Activity

0 active trials
Showing 5 of 20
completedphase_2

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

NCT00354393
completedphase_1

Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction

NCT00540982
completedphase_2

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00005847
completedphase_2

Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer

NCT00006682
completedphase_2

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation

NCT00003963
View all 20 trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT00354393Phase 2

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Completed
NCT00540982Phase 1

Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction

Completed
NCT00005847Phase 2

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Completed
NCT00006682Phase 2

Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer

Completed
NCT00003963Phase 2

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation

Completed
NCT00075673Phase 1

Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer

Terminated
NCT00002583Phase 3

Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed

Completed
NCT00266110Phase 2

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Completed
NCT00088985Phase 2

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Terminated
NCT00828074Phase 1

Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer

Completed
NCT00881387Phase 2

Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment

Withdrawn
NCT01155258Phase 1

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Completed
NCT00795678

Chemotherapeutic Agents in Brain/Breast

Completed
NCT00055887Phase 3

Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer

Withdrawn
NCT00014430Phase 1

Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer

Completed
NCT00004096Phase 1

Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Completed
NCT00389922Phase 1

Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors

Completed
NCT00004105Phase 1

Combination Chemotherapy in Treating Patients With Advanced Cancer

Completed
NCT00057798Phase 2

Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery

Completed
NCT00006372Phase 1

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20